Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas to Transfer Manufacturing Plant to Delpharm | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Astellas to Transfer Manufacturing Plant to Delpharm

Plant will produce medicines in solid forms.

By: Anthony Vecchione

Astellas will transfer its manufacturing plant and business based in Meppel, the Netherlands to Delpharm. The definitive agreement will be executed after completing works council consultation and local legal and regulatory requirements.

This manufacturing plant, fully equipped with state-of-the-art technologies, employs 332 personnel who contribute to the production of medicines in solid forms.

The Meppel site holds most of the quality authorizations for exporting to the world, including FDA certification for the U.S.

With this additional site, Delpharm will strengthen its position in the Netherlands where the CDMO already owns one manufacturing site in Bladel and an injectable drug development center in Leiden.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics